Wellbutrin vs. Zoloft: How Two Common Antidepressants Compare

Wellbutrin (generic name bupropion) and Zoloft (generic name sertraline) are commonly prescribed antidepressants in the United States, but they belong to different drug classes and work in very different ways. 

Wellbutrin acts mainly on the brain chemicals norepinephrine and dopamine, while Zoloft is a selective serotonin reuptake inhibitor, or SSRI, that primarily affects serotonin. Understanding how they differ in their approved uses, side effects, and everyday effects can help you have a more informed conversation with your provider about which one may work better for you.

Key Takeaways

• Different mechanisms, different strengths: Wellbutrin is a norepinephrine and dopamine reuptake inhibitor (NDRI) often considered when minimizing sexual side effects or avoiding sedation is a priority, while Zoloft is an SSRI approved for a wider range of conditions, including several anxiety disorders.

• The right choice depends on you: Your diagnosis, other medications, past side effects, individual response to medication, and personal goals all shape which medication is a better starting point. Some people notice early changes within the first few weeks, but antidepressants generally take several weeks to show their full benefit. Your provider may put you on an antidepressant for 6-8 weeks at a therapeutic dose to know if it is working.

• Both are well established and generic: Each has decades of clinical use and is available as an affordable generic. Neither should be started, stopped, or switched without guidance from a prescriber.

What Are Wellbutrin and Zoloft?

Although both Wellbutrin and Zoloft are approved to treat depression, the medications belong to separate classes of antidepressants, which explains their distinct mechanisms and side effect profiles.

Wellbutrin (Bupropion)

Wellbutrin is the brand name for bupropion, an antidepressant first approved by the FDA in 1985. It is often described as an atypical antidepressant because it does not fit into the more common SSRI or SNRI categories. It comes in three formulations: Wellbutrin IR (immediate-release), Wellbutrin SR (sustained-release), and Wellbutrin XL (extended-release). Of these, Wellbutrin SR and Wellbutrin XL are more often prescribed.

Wellbutrin XL, the extended-release version, is approved to treat major depressive disorder and seasonal affective disorder, and under the brand name Zyban, it is also approved to help people quit smoking. 

Because it can be energizing rather than sedating, it is sometimes prescribed for people whose depression presents with symptoms including low energy or trouble concentrating. Wellbutrin is associated with a low risk of sexual dysfunction and weight gain, which can be a deciding factor for some people who experience these side effects on SSRI/SNRI antidepressants.

Zoloft (Sertraline)

Zoloft is the brand name for sertraline, an SSRI antidepressant approved by the FDA in 1991. SSRIs are considered a first-line treatment for depression and anxiety because of their long safety record and strong evidence base. Zoloft has one of the broadest approval profiles of any SSRI, which makes it a flexible option for people who have more than one condition. 

Zoloft primarily works on the serotonin signalling system, which is understood to produce the antidepressant and anxiolytic (anti-anxiety) effects over time.

How Do They Work in the Brain?

The main difference between these medications lies in the brain chemicals they act on. Wellbutrin (bupropion) blocks the reuptake of norepinephrine and dopamine, increasing the availability of these neurotransmitters for signaling between nerve cells. These changes in neurotransmitter signaling may contribute to improvement in symptoms such as low energy, motivation, and concentration when treating depression. However, the exact mechanism underlying Wellbutrin’s antidepressant effects isn’t fully understood.

Zoloft (sertraline) blocks the reabsorption of serotonin into presynaptic nerve cells, which leaves more of it available for signaling between nerve cells. Over time, this modulates the activity and sensitivity of serotonin receptors and other neural pathways. Serotonin is a chemical involved in regulating mood, sleep, and anxiety. These longer-term changes in serotonin signaling are thought to contribute to improvements in mood and anxiety. 

Because serotonin plays a large role in anxiety, Zoloft is typically used for anxiety disorders. This is also supported by a strong evidence base for Zoloft. Wellbutrin is not FDA-approved for anxiety disorders, though this doesn’t necessarily mean it doesn’t work for anxiety. In fact, Wellbutrin may help in some cases where anxiety is associated with depression.

FDA-Approved Uses

The conditions each medication is officially approved to treat reflect their different mechanisms. The lists below show where each drug has the strongest regulatory backing.

What Wellbutrin is Approved to Treat

• Major depressive disorder (MDD) in adults

• Seasonal affective disorder, a form of depression that follows a seasonal pattern

• Smoking cessation, when prescribed under the brand name Zyban

Wellbutrin is also used off-label for conditions such as ADHD and to reduce the sexual side effects that other antidepressants can cause. Off-label means a provider prescribes it for a use the FDA has not formally approved, which is a common and legal practice when the evidence supports it.

What Zoloft is Approved to Treat

• Major depressive disorder (MDD)

• Obsessive-compulsive disorder (OCD) in adults and children aged 6 and older

• Panic disorder

• Post-traumatic stress disorder (PTSD)

• Social anxiety disorder

• Premenstrual dysphoric disorder (PMDD)

This wider range of approvals is one reason Zoloft is often chosen for people who have both depression and an anxiety-related condition. 

Comparing Effectiveness

Both Wellbutrin (bupropion) and Zoloft (sertraline) are established treatment options for major depressive disorder, and neither is universally better for everyone. A large 2018 network meta-analysis published in The Lancet found that both bupropion and sertraline were effective antidepressants.

Sertraline was among the medications with a favorable tolerability profile, but differences between antidepressants were generally modest. However, what matters most is how your body responds, since two people with the same diagnosis can respond differently to the same medication.

A 2008 meta analysis involving over 2,800 patients compared the efficacy of bupropion with SSRIs as a class in the treatment of anxiety symptoms in major depression (anxious depression). The study concluded that both bupropion and SSRIs were comparable in the anxiolytic effect they produced.

Thus, Wellbutrin may be considered in cases where a patient with anxious depression doesn’t respond sufficiently to SSRIs.

More generally, when low energy or fatigue is a prominent symptom in depression, some providers may consider Wellbutrin because it can be activating for some people.

When someone has a diagnosed anxiety disorder or OCD in addition to depression, Zoloft may be preferred because it has an established evidence base and FDA approvals for several of these conditions.

With both antidepressants, many people notice early shifts in sleep or energy within one to two weeks, but the full effect on mood generally takes several weeks to build.

Dosing Basics

Dosing differs between the two, partly because Wellbutrin comes in several formulations. These are general ranges, and your provider will personalize your dose.

• Wellbutrin: Available in immediate-release, sustained-release (SR), and extended-release (XL) forms. The FDA label for Wellbutrin XL recommends 150 mg once daily in the morning, increasing after 4 days to 300 mg once daily for MDD. For Wellbutrin SR, the starting dose is 150 mg/day, which can be increased after 3 days to 150 mg twice daily with an 8-hour gap. The formulations have different dosing schedules, which help maintain appropriate drug levels and reduce the risk of adverse effects, including seizures.

• Zoloft: The FDA label recommends starting at 25 to 50 mg per day, and it may be increased gradually up to a maximum of 200 mg per day. Dose changes can be made in 25-50 mg/day increments once a week.

Because Wellbutrin can be activating, providers often advise taking it earlier in the day to avoid trouble sleeping. It can take a few weeks to feel the full benefit, and it helps to know beforehand the signs that Wellbutrin is working and how long it can take for visible results..

Side Effects: What to Expect

Because these medications work on different brain chemicals, their side effect profiles differ in ways that often guide the decision. Two differences stand out: sexual side effects and seizure risk.

Wellbutrin is associated with a low risk of sexual side effects, which is one reason it is sometimes added to or chosen over an SSRI. It can, however, cause insomnia, dry mouth, headache, and a jittery or anxious feeling in some people. Moreover, it has a dose-related seizure risk, which is one reason it is contraindicated in people with seizure disorders and certain eating disorders and must be dosed carefully.

Zoloft shares the common SSRI side effects, including nausea (especially in the first couple of weeks), headache, dizziness, fatigue, diarrhea, sleep changes, and sexual side effects such as lower desire or delayed orgasm. For many people, these effects are mild and ease over the first few weeks as the body adjusts.

Both carry a boxed warning, the FDA’s strongest warning, about a possible increase in suicidal thoughts in children, teens, and young adults, especially in the first weeks of treatment or after a dose change. Anyone starting either medication should be watched closely during this period and should reach out to their provider if mood worsens.

Key Differences That May Guide the Choice

When providers weigh Wellbutrin against Zoloft, a few practical points tend to drive the decision.

• Anxiety: Zoloft treats several anxiety disorders, while Wellbutrin can sometimes increase anxiety or restlessness. For anxious depression, which is not an anxiety disorder but is primarily depression wth anxiety symptoms, Wellbutrin may be considered if SSRIs don’t provide adequate response.

• Sexual side effects: Wellbutrin is generally associated with fewer sexual side effects than SSRIs and is sometimes used to counter this effect from other antidepressants.

• Energy and focus: Wellbutrin can feel activating for some people, which can help with fatigue and concentration.

• Weight: Wellbutrin is often weight-neutral or linked with slight weight loss, while responses to Zoloft vary from person to person.

• Seizure history or eating disorders: Wellbutrin is contraindicated in people with a seizure disorder or a current or prior diagnosis of eating disorders like anorexia nervosa or bulimia nervosa.

• Sleep: Wellbutrin can interfere with sleep if taken late in the day; Zoloft may cause either drowsiness or insomnia.

Which One Might Be Right for You?

There is no universally better option, because both are effective, well-studied antidepressants. The right fit depends on your specific diagnosis, your history with other medications, your current prescriptions, and what side effects you most want to avoid. 

Someone with depression and a diagnosed anxiety disorder may be more likely to consider Zoloft, while someone with depression, low energy, and a history of sexual side effects on an SSRI may do better with Wellbutrin. In some cases, a provider may add Wellbutrin to an SSRI to help reduce sexual side effects while maintaining the antidepressant benefits of the SSRI.

If the first medication does not help enough after an adequate trial, adjusting the dose, switching to a different medication, , or combining medication with psychotherapy are all common and reasonable next steps. These decisions should always be made with a prescriber rather than on your own.

How Blossom Health Can Help

Choosing between antidepressants is easier with a knowledgeable provider who knows your history. Blossom Health is a telehealth psychiatry platform that connects you with board-certified, licensed psychiatric providers for virtual, in-network care. Getting started takes three simple steps.

• Share your details: Enter your state of residence and your insurance plan so we can match you with the right provider.

• Choose a time: Pick an appointment slot that works for your schedule, often within days.

• Meet your provider: Confirm a few more details, then meet with your provider by video to review your history, symptoms, and goals and build a personalized plan.

If your mental health is holding you back, you do not have to sort through medication options alone. You can start with Blossom Health and work with a provider who can help you weigh Wellbutrin, Zoloft, and other options for your situation.

Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.

Sources

1. U.S. Food and Drug Administration. (2024, March). Wellbutrin XL (bupropion hydrochloride extended-release) tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021515s046lbl.pdf 

2. Huecker MR, Smiley A, Saadabadi A. Bupropion. [Updated 2024 Sep 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470212/ 

3. Singh HK, Saadabadi A. Sertraline. [Updated 2023 Feb 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547689/ 

4. Cipriani, A., Furukawa, T. A., Salanti, G., et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357–1366. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/fulltext 

5. Papakostas, G. I., Trivedi, M. H., Alpert, J. E., et al. (2008). Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: A meta-analysis of individual patient data from 10 double-blind, randomized clinical trials. Journal of Psychiatric Research, 42(2), 134–140. https://www.sciencedirect.com/science/article/abs/pii/S0022395607000969 

6. National Institute of Mental Health. (2023, December). Mental health medications. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/mental-health-medications 

7. U.S. Food and Drug Administration. (2025, November). Wellbutrin SR (bupropion hydrochloride) sustained-release tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020358s070lbl.pdf 

8. U.S. Food and Drug Administration. (2023, August). Zoloft (sertraline hydrochloride) tablets and oral solution: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf 

9. Sheffler ZM, Patel P, Abdijadid S. Antidepressants. [Updated 2026 Jul 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538182/ 

10. Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554406/